Biodexa Pharmaceticals (BDRX) — Net Asset Quality Index
Biodexa Pharmaceticals (BDRX) has a Net Asset Quality Index of 62.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $18.15 Million minus total liabilities of $6.76 Million yields net assets of $11.38 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does Biodexa Pharmaceticals carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Biodexa Pharmaceticals Net Asset Quality Index Over Time (2012–2025)
This chart shows how Biodexa Pharmaceticals's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the index stands at 62.7%, representing net assets of $11.38 Million against total assets of $18.15 Million USD. For live market cap and overall valuation, see Biodexa Pharmaceticals stock valuation.
Annual Net Asset Quality Index for Biodexa Pharmaceticals (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Biodexa Pharmaceticals from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check BDRX capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 62.7% | $11.38 Million | $18.15 Million | $6.76 Million | ▲ +6.4 pp |
| 2024 | 56.3% | $8.32 Million | $14.78 Million | $6.46 Million | ▲ +11.9 pp |
| 2023 | 44.4% | $4.68 Million | $10.54 Million | $5.86 Million | ▼ -12.9 pp |
| 2022 | 57.2% | $3.16 Million | $5.53 Million | $2.36 Million | ▼ -23.7 pp |
| 2021 | 80.9% | $10.45 Million | $12.91 Million | $2.46 Million | ▲ +12.5 pp |
| 2020 | 68.4% | $6.72 Million | $9.82 Million | $3.10 Million | ▲ +5.1 pp |
| 2019 | 63.3% | $19.56 Million | $30.89 Million | $11.34 Million | ▼ -19.5 pp |
| 2018 | 82.8% | $16.92 Million | $20.44 Million | $3.52 Million | ▲ +12.3 pp |
| 2017 | 70.4% | $34.68 Million | $49.22 Million | $14.55 Million | ▼ -10.2 pp |
| 2016 | 80.7% | $45.72 Million | $56.69 Million | $10.96 Million | ▲ +7.4 pp |
| 2015 | 73.2% | $46.89 Million | $64.04 Million | $17.15 Million | ▼ -16.8 pp |
| 2014 | 90.0% | $41.99 Million | $46.66 Million | $4.67 Million | ▲ +75.3 pp |
| 2013 | 14.7% | $760.00K | $5.17 Million | $4.41 Million | ▲ +243.9 pp |
| 2012 | -229.2% | $-8.28 Million | $3.61 Million | $11.89 Million | — |